Abstract

Outcomes after Autologous Stem Cell Transplant in Patients with Relapsed Multiple Myeloma

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Selinexor in Combination with Pomalidomide and Dexamethasone (SPd) for Treatment of Patients with Relapsed Refractory Multiple Myeloma (RRMM)
Heidi Sheehan ...
Blood | VOL. 136
Heidi Sheehan, et. al.Heidi Sheehan ...
05 Nov 2020
HORIZON (OP-106): Melflufen Plus Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma-Age Subgroup Analysis of Elderly Patients
Maxim Norkin ... John W Hiemenz
Blood | VOL. 136
Maxim Norkin, et. al.Maxim Norkin ... John W Hiemenz
05 Nov 2020
Selinexor, Lenalidomide and Dexamethasone (SRd) for Patients with Relapsed/Refractory and Newly Diagnosed Multiple Myeloma
Nizar J Bahlis ... Rami Kotb
Blood | VOL. 136
Nizar J Bahlis, et. al.Nizar J Bahlis ... Rami Kotb
05 Nov 2020
HORIZON (OP-106): Melflufen Plus Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma with High-Risk Cytogenetics-Subgroup Analysis
Agne Paner ... Anastasios Raptis
Blood | VOL. 136
Agne Paner, et. al.Agne Paner ... Anastasios Raptis
05 Nov 2020
View more papers

More From: Blood

Paper Title
Journal
Date
Author
EVIDENCE meta-analysis: evaluating minimal residual disease as an intermediate clinical endpoint for multiple myeloma.
Ola Landgren ... Sean M Devlin
Blood | VOL. -
Ola Landgren, et. al.Ola Landgren ... Sean M Devlin
20 May 2024
Increased risk of venous thromboembolism in young and middle-aged individuals with hereditary angioedema: a family study.
Linda Sundler Björkman ... Bengt Zöller
Blood | VOL. -
Linda Sundler Björkman, et. al.Linda Sundler Björkman ... Bengt Zöller
17 May 2024
Mutational profile of previously treated chronic lymphocytic leukemia patients progressing on acalabrutinib or ibrutinib.
Jennifer A Woyach ... Veerendra Munugalavadla
Blood | VOL. -
Jennifer A Woyach, et. al.Jennifer A Woyach ... Veerendra Munugalavadla
16 May 2024
Outcomes of younger patients with mantle-cell lymphoma experiencing late relapse (>24 months): the LATE-POD study.
Chiara Malinverni ... Carlo Visco
Blood | VOL. -
Chiara Malinverni, et. al.Chiara Malinverni ... Carlo Visco
16 May 2024
View more papers